0001731122-20-000116.txt : 20200210
0001731122-20-000116.hdr.sgml : 20200210
20200210175920
ACCESSION NUMBER: 0001731122-20-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190827
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finestone Arnold
CENTRAL INDEX KEY: 0001422489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09927
FILM NUMBER: 20593225
MAIL ADDRESS:
STREET 1: 1211 N. WESTSHORE BLVD.
STREET 2: SUITE 512
CITY: TAMPA
STATE: FL
ZIP: 33607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Advanzeon Solutions, Inc.
CENTRAL INDEX KEY: 0000022872
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 952594724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
BUSINESS PHONE: 813-288-4808
MAIL ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
FORMER COMPANY:
FORMER CONFORMED NAME: COMPREHENSIVE CARE CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES
DATE OF NAME CHANGE: 19730501
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC
DATE OF NAME CHANGE: 19700402
4
1
ownership.xml
X0306
4
2019-08-27
0
0000022872
Advanzeon Solutions, Inc.
CHCR
0001422489
Finestone Arnold
C/O 2901 W. BUSCH BLVD., SUITE 701
TAMPA
FL
33618
1
1
0
0
CFO
Common Stock
2019-08-27
4
J
0
5000000
.00
A
6577171
D
The Board of Directors on August 26, 2019, changed the vesting date of the Issuer's Series D Preferred Stock from January 4, 2022, to August 27, 2019. Each share of the Series D Preferred Stock converts into 100,000 shares of Issuer's Common Stock. The Reporting Person owns 50 shares of the Series D Preferred Stock which are convertible into 5,000,000 shares of the Issuer's Common Stock.
Represents 1,000,000 shares subject to options. 500,000 shares acquirable with a warrant, 77,171 shares obtainable from the conversation of 244 shares of the Issuer's Series C Preferred Stock and 50 shares of the Issuer's Series D Preferred Stock obtainable from the conversion of the Series D Preferred Stock.
/s/ Arnold B. Finestone
2020-02-10